{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+%28for+azithromycin%29&page=3", "query": { "intervention": "placebo (for azithromycin)", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 62, "total_pages": 7, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+%28for+azithromycin%29&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=placebo+%28for+azithromycin%29&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T07:28:47.001Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00358462", "title": "Mycoplasma Genitalium Antibiotic Susceptibility and Treatment (MEGA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urethritis" ], "interventions": [ { "name": "Azithromycin", "type": "DRUG" }, { "name": "Doxycycline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Washington", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "16 Years", "maximum_age": null, "sex": "MALE", "summary": "16 Years and older · Male only" }, "enrollment_count": 606, "start_date": "2007-01", "completion_date": "2011-11", "has_results": true, "last_update_posted_date": "2018-08-15", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00358462" }, { "nct_id": "NCT03801252", "title": "Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Obesity", "Induction of Labor Affected Fetus / Newborn" ], "interventions": [ { "name": "Cefazolin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Oklahoma", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "15 Years", "maximum_age": "45 Years", "sex": "FEMALE", "summary": "15 Years to 45 Years · Female only" }, "enrollment_count": 186, "start_date": "2018-12-12", "completion_date": "2021-06-01", "has_results": true, "last_update_posted_date": "2024-04-19", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 1, "location_summary": "Oklahoma City, Oklahoma", "locations": [ { "city": "Oklahoma City", "state": "Oklahoma" } ], "official_url": "https://clinicaltrials.gov/study/NCT03801252" }, { "nct_id": "NCT02024555", "title": "Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sarcoidosis; Antimycobacterial Therapy" ], "interventions": [ { "name": "Levofloxacin", "type": "DRUG" }, { "name": "Ethambutol", "type": "DRUG" }, { "name": "Azithromycin", "type": "DRUG" }, { "name": "Rifampin", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 97, "start_date": "2014-03", "completion_date": "2019-04-01", "has_results": true, "last_update_posted_date": "2020-07-09", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 6, "location_summary": "Albany, New York • Cincinnati, Ohio • Cleveland, Ohio + 3 more", "locations": [ { "city": "Albany", "state": "New York" }, { "city": "Cincinnati", "state": "Ohio" }, { "city": "Cleveland", "state": "Ohio" }, { "city": "Columbus", "state": "Ohio" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02024555" }, { "nct_id": "NCT01272635", "title": "Treatment of Preschool Children With Upper Respiratory Tract Illnesses Using Azythromycin and Lower Respiratory Tract Symptoms Using Oral Corticosteroids.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma", "Wheezing" ], "interventions": [ { "name": "Azithromycin", "type": "DRUG" }, { "name": "Prednisolone", "type": "DRUG" }, { "name": "Placebo Azithromycin", "type": "OTHER" }, { "name": "Placebo Prednisolone", "type": "DRUG" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Milton S. Hershey Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Months", "maximum_age": "71 Months", "sex": "ALL", "summary": "12 Months to 71 Months" }, "enrollment_count": 607, "start_date": "2011-03", "completion_date": "2015-01", "has_results": true, "last_update_posted_date": "2016-12-28", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 16, "location_summary": "Tucson, Arizona • Oakland, California • San Francisco, California + 11 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Oakland", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT01272635" }, { "nct_id": "NCT05026801", "title": "Azithromycin Plus Hydroxychloroquine for COVID-19 Infection", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Respiratory Tract Infection Viral" ], "interventions": [ { "name": "Azithromycin plus hydroxychloroquine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Iterum Therapeutics, International Limited", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 0, "start_date": "2021-02-08", "completion_date": "2021-08-26", "has_results": false, "last_update_posted_date": "2021-10-28", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 1, "location_summary": "Waterbury, Connecticut", "locations": [ { "city": "Waterbury", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT05026801" }, { "nct_id": "NCT01014078", "title": "A Four Week Study of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Dry Eye Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Dry Eye Disease" ], "interventions": [ { "name": "Azithromycin Ophthalmic Solution, 1%", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 112, "start_date": "2009-10", "completion_date": "2010-03", "has_results": false, "last_update_posted_date": "2011-09-26", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 9, "location_summary": "Artesia, California • Newport Beach, California • Petaluma, California + 6 more", "locations": [ { "city": "Artesia", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Petaluma", "state": "California" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Kansas City", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01014078" }, { "nct_id": "NCT06418711", "title": "ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "MAC Lung Disease", "Treatment Refractory MAC Lung Disease", "Mycobacterium Infections, Nontuberculous" ], "interventions": [ { "name": "Clofazimine Inhalation Suspension", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mannkind Corporation", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 132, "start_date": "2024-09-11", "completion_date": "2025-11-10", "has_results": false, "last_update_posted_date": "2025-11-12", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 54, "location_summary": "Birmingham, Alabama • Fresno, California • Los Angeles, California + 47 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fresno", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Newport Beach", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06418711" }, { "nct_id": "NCT00892970", "title": "The Effects of Azithromycin Ophthalmic Solution, 1% Versus Placebo in Subjects With Blepharitis During a Two-Week Treatment Period", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Blepharitis" ], "interventions": [ { "name": "Azithromycin ophthalmic solution, 1%", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Merck Sharp & Dohme LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 313, "start_date": "2009-04", "completion_date": "2010-01", "has_results": false, "last_update_posted_date": "2011-09-26", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 33, "location_summary": "Little Rock, Arkansas • Artesia, California • Azusa, California + 29 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Artesia", "state": "California" }, { "city": "Azusa", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Mission Hills", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00892970" }, { "nct_id": "NCT00431964", "title": "Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "azithromycin 250 mg tablets", "type": "DRUG" }, { "name": "placebo tablets", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "CF Therapeutics Development Network Coordinating Center", "sponsor_class": "NETWORK", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "18 Years", "sex": "ALL", "summary": "6 Years to 18 Years" }, "enrollment_count": 263, "start_date": "2007-02", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2015-08-19", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Hartford, Connecticut • Atlanta, Georgia + 27 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Indianapolis", "state": "Indiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT00431964" }, { "nct_id": "NCT01074554", "title": "Trial of Antimycobacterial Therapy in Sarcoidosis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Sarcoidosis" ], "interventions": [ { "name": "Antibiotic Regimen", "type": "DRUG" }, { "name": "Placebo Regimen", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Vanderbilt University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 30, "start_date": "2010-02", "completion_date": "2011-02", "has_results": true, "last_update_posted_date": "2016-12-12", "last_synced_at": "2026-10-09T07:28:47.001Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01074554" } ] }